TrialArteriosclerosis, thrombosis, and vascular biology2019

ApoC-III Glycoforms Are Differentially Cleared by Hepatic TRL (Triglyceride-Rich Lipoprotein) Receptors.

Natalie C Kegulian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.